Cancer Research Horizons (investor - Corporate Investor)
See something wrong or missing? Let us know
Offices:London
Cancer Research Horizons is a British specialist drug discovery, development and commercialisation company
Average round investment:33.81M USD
Average number per year:1.3
Distribution:
2025 (1)2024 (2)2023 (1)
Portfolio companies:
Trogenix
52 North Health
Infinitopes



Mostly invests in:
United Kingdom (4)
Manufacturing (4)

See the entire list
Showing 3 of 4 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Cancer Research Horizons
Name | Criteria | |
---|---|---|
![]() |
What If Ventures
83%
|
|
![]() |
Unilever Ventures
83%
|
|
![]() |
⌘ Cmd + N
83%
|
|
![]() |
HG Ventures
83%
|
|
![]() |
Mandatum Asset Management
83%
|
|
![]() |
A.Capital Ventures
83%
|
|
![]() |
Jim O’Neill
83%
|
|
![]() |
Shasta Ventures
83%
|
|
![]() |
PS Capital
83%
|
|
![]() |
InterAlpen Partners
83%
|
|